Small peptides mimicking substance P (1-7) and encompassing a C-terminal amide functionality

Area of Science:

• Neuroscience
• Peptide Chemistry

Background:

• Substance P (SP) exerts biological effects, some mediated by its metabolite SP(1-7).
• SP(1-7) exhibits unique actions, distinct from SP, and binds to specific sites separate from NK receptors.
• Understanding SP(1-7) binding is crucial for elucidating its physiological roles.

Purpose of the Study:

• To investigate the structure-activity relationships of the bioactive peptide SP(1-7).
• To identify key residues and modifications influencing SP(1-7) binding affinity.

Main Methods:

• Alanine scanning mutagenesis of SP(1-7) to assess residue importance.
• N-terminal truncation of SP(1-7) to evaluate sequence requirements.
• Synthesis of C-terminally amidated SP(1-7) analogs.
• Binding affinity assays to quantify ligand-receptor interactions.

Main Results:

• The C-terminal phenylalanine (Phe7) of SP(1-7) is critical for binding; its replacement with alanine abolishes activity.
• N-terminal truncation retains binding activity but reduces affinity compared to SP(1-7).
• C-terminal amidation of SP(1-7) and its truncated analogs significantly enhances binding affinity (5-10 fold).

Conclusions:

• The C-terminus of SP(1-7), particularly Phe7, is essential for receptor interaction.
• Peptide length and C-terminal modification are key determinants of SP(1-7) binding.
• C-terminal amidation represents a promising strategy for developing potent SP(1-7) analogs.